Back
Pershing Resources Vs. Monopar Therapeutics Industry Stock Comparison
Buy
57
PSGR
Pershing Resources
Last Price:
$0.0200
Seasonality Move:
7.85%
Buy
62
MNPR
Monopar Therapeutics
Last Price:
$42.88
Seasonality Move:
-18.4%
Buy
57
Pershing Resources (PSGR)
is a Buy
Is Pershing Resources a Buy, Sell or Hold?
-
The current Pershing Resources [PSGR] share price is $0.0175. The Score for PSGR is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
PSGR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $43.10. The Score for MNPR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PSGR Stock Price Chart
What is Pershing Resources's stock price today?
-
The Pershing Resources share price today is $0.0175Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSGR is experiencing buying pressure, which is a positive indicator for future bullish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $43.10The current trend is moderately bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PSGR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 60.63 | Buy |
Chaikin Money Flow: | 73000 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.0154 - 0.0154) | Buy |
Bollinger Bands (100): | (0.0172 - 0.0172) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.09 | Buy |
Relative Strength Index (14 RSI): | 54.79 | Buy |
Chaikin Money Flow: | 42632 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.73 - 48.15) | Buy |
Bollinger Bands (100): | (9.13 - 35.11) | Buy |
PSGR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.02 | Buy |
20-day SMA: | 0.02 | Buy |
50-day SMA: | 0.02 | Buy |
200-day SMA: | 0.02 | Sell |
8-day EMA: | 0.02 | Buy |
20-day EMA: | 0.02 | Buy |
50-day EMA: | 0.02 | Buy |
200-day EMA: | 0.02 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.23 | Sell |
20-day SMA: | 42.63 | Buy |
50-day SMA: | 31.85 | Buy |
200-day SMA: | 12.72 | Buy |
8-day EMA: | 46.52 | Sell |
20-day EMA: | 42.49 | Buy |
50-day EMA: | 33.84 | Buy |
200-day EMA: | 17.46 | Buy |
Pershing Resources Earnings Growth & PSGR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Pershing Resources Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |